State
73,213 recalls have nationwide distribution and so reach Arizona. 8,387 additional recalls listed Arizona specifically in their distribution scope.
Of the 8,387 recalls naming Arizona we have scored against our rubric, 1,313 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,720 (21%) are Severe.
Which agencies issued them
These figures cover only the 8,387 recalls whose distribution notice names Arizona specifically. The 73,213 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Toyota is recalling 2022-2023 Tundra and Tundra Hybrid vehicles because the plastic fuel tube may chafe against brake lines and leak fuel, creating a fire risk.
Chrysler is recalling certain 2023 Jeep Wrangler vehicles because the spare tire may obstruct the center high-mount brake light, reducing visibility to other drivers and increasing crash risk.
Isuzu is recalling 19,479 trucks because a wire seal defect may allow water intrusion, causing fuse corrosion and potential loss of engine power.
Saxco International is recalling about 8,370 glass carboys because the glass can break due to improper cooling processes, posing a laceration hazard. The firm has received 30 reports of incidents of glass breaking, though no injuries have been reported.
Target is recalling about 2.2 million Threshold Glass Jar Candles because the glass jars can crack or break during use, posing laceration and burn hazards. Target received 19 reports of jars breaking or cracking, resulting in one minor injury.
The Impella RP Flex cardiac pump has been recalled due to a higher-than-expected rate of blood clot formation. Blood clots may reduce cardiac support or cause hemolysis.
Lupin Pharmaceuticals is recalling TYDEMY birth control tablets due to failed stability testing. Consumers should contact their healthcare provider.
Central Admixture Pharmacy Services recalls Cardioplegia Solution (Lot 36-253947) due to lack of sterility assurance and insufficient decontamination validation. Healthcare facilities should discontinue use and contact the manufacturer.
Central Admixture Pharmacy Services is recalling fentanyl injections because sterilization procedures were not properly validated, raising infection risks from potential contamination.
Central Admixture Pharmacy Services is recalling 244 neonatal TPN IV bags due to lack of assurance that the sterility process was validated. The manufacturer lacked adequate validation data for their decontamination cycles.
Medline Industries is recalling 211 custom procedural kits (egg retrieval, fetal surgery, TVT packs) worldwide because the sterile ultrasound gel component may not meet sterility specifications. Kits were distributed between April 2020 and April 2023.
Olympus SPiN Drive Forceps are being recalled due to an electromagnetic sensor malfunction that disables navigation functionality during endobronchial procedures, potentially causing procedural delays. No injuries reported.
FDA recalls 130,250 bags of oxyTOCIN IV solution from CAPS, Inc., distributed nationwide, due to lack of validated sterilization procedures. No illnesses reported.
NeuMoDx Molecular Inc is recalling 20,016 cartridges from three lots due to incorrect label placement during manufacturing. Misplaced labels may interfere with optical performance, increasing risk for false positive test results.
Central Admixture Pharmacy Services is recalling 497 bags of OxyTOCIN IV bags nationwide due to lack of validated sterility assurance. The manufacturer's decontamination validation data is insufficient.
Medline is recalling 1,231,480 Probe Cover Kits distributed worldwide due to potential sterility specification failures in the ultrasound gel component.
Medline is recalling pediatric electrophysiology procedural kits because the ultrasound gel component may not meet sterility specifications. The recall affects 192 kits distributed worldwide from April 2020 to April 2023.
Central Admixture Pharmacy Services has recalled Cardioplegia Solution due to lacking sterility assurance and insufficient validation data for decontamination cycles. The recall affects 148 bags distributed nationwide.
Central Admixture Pharmacy Services recalls 1,937 bags of oxytocin 10 units in Lactated Ringer's IV bags nationwide due to insufficient sterility assurance and missing validation data for decontamination cycles.
Central Admixture Pharmacy Services recalls 1,235 morphine syringes nationwide due to lack of validation data for sterilization cycles, potentially compromising sterility.
Central Admixture Pharmacy Services is recalling Cardioplegia Solution due to lacking validation data for decontamination cycles, creating insufficient assurance of sterility in this injectable product.
Shimadzu ceiling tube supports used with X-ray systems may have loose or missing fixing bolts at the base. The company is providing service to install cables and brackets to prevent the device from falling.
Central Admixture Pharmacy Services is recalling 2,077 syringes of HYDROmorphone injection (15 mg/30 mL) distributed nationwide due to lack of validation data for sanitization cycles. No adverse events have been reported.
Central Admixture Pharmacy Services recalled 96 neonatal TPN IV bags (Lot 36-256336) due to lack of sterility assurance and missing validation data for decontamination cycles. The product was distributed nationwide.
A latching mechanism in the ACROBAT-i Vacuum Stabilizer System may fail during cardiac surgery, potentially causing loss of heart stabilization or device component release. The defect affects 334 units distributed worldwide.